Delivery Order SPE2DB20D2104-SPE2DB25FMGDH
Award Date
1/15/25
Potential Completion Date
2/6/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is a Firm Fixed Price Delivery Order for a pharmaceutical product called LONSURF 15 MG-6.14 MG TABLET 40S. The award has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,406.92, is for the delivery of the medication LONSURF 20 MG-8.19 MG TABLET 20S. The contract is a Firm Fixed Price Delivery Order with a completion date of February 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,173.33 firm fixed-price delivery order is for the supply of the medication LONSURF 20 MG-8.19 MG TABLET 60S, with a performance period ending on March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This contract award, with ID SPE2DB20D3303|SPE2DB25FY3R0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,835.01 Firm Fixed Price Delivery Order is for the supply of LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $9,599.25, is a Firm Fixed Price Delivery Order to provide the pharmaceutical product LONSURF 20 MG-8.19 MG TABLET 60S. This contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $16,850.90 firm-fixed-price delivery order is for the supply of the prescription medication LONSURF 20 MG-8.19 MG TABLET 60S, with a performance period through May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.59 firm-fixed-price delivery order is for the supply of TLANDO 112.5 MG CAPSULE 120S to support federal healthcare programs. The contract has an ultimate completion date of January 22, 2025. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,071.16, is a delivery order for the product "TLANDO 112.5 MG CAPSULE 120S" with a completion date of January 22, 2025. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $25,656.54 and a completion date of September 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 100 mg tablets of the drug Lorbrena, with a ceiling value of $10,578.39 and a performance period through February 2, 2024. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company...